VF
FBRX icon

Virtu Financial’s Forte Biosciences FBRX Stock Holding History

Virtu Financial’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-566
Closed -$15K – 1781
2022
Q3 		$15K Buy
+566
New +$18K ﹤0.01% 1458
2021
Q2 		– Sell
-247
Closed -$212K – 1679
2021
Q1 		$212K Buy
+247
New +$202K 0.02% 1049
2019
Q4 		– Sell
-34
Closed -$8K – 1554
2019
Q3 		$8K Buy
+34
New +$51.6K ﹤0.01% 1360

Other funds holding FBRX

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial's FBRX Position: Q4 2022 in Review

Virtu Financial sold out of Forte Biosciences (FBRX) in Q4 2022, closing a stake of 566 shares — an estimated $15K sold.

Virtu Financial first reported a position in FBRX in Q3 2019 and held it in 3 quarters. The position peaked at $212K in Q1 2021. 34 funds tracked by Wall St. Rank hold FBRX as of Q4 2022.

  • Virtu Financial reported no remaining Forte Biosciences position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 566 Forte Biosciences shares in Q4 2022, an estimated $15K.
  • Virtu Financial first reported a position in Forte Biosciences in Q3 2019 and held it in 3 quarters.
  • Virtu Financial's Forte Biosciences position peaked at $212K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.